Neil Exter - Jun 17, 2022 Form 4 Insider Report for Decibel Therapeutics, Inc. (DBTX)

Role
Director, 10%+ Owner
Signature
/s/ Elisabeth Leiderman, Attorney-in-Fact
Stock symbol
DBTX
Transactions as of
Jun 17, 2022
Transactions value $
$0
Form type
4
Date filed
6/21/2022, 06:45 PM
Previous filing
Jun 17, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DBTX Stock Option (right to buy) Award $0 +10K $0.00 10K Jun 17, 2022 Common Stock 10K $2.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on June 17, 2022 for 10,000 shares. The shares underlying the option are scheduled to vest in full on the one year anniversary of the date of grant of the option (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the option), subject to the reporting person's continued service.